Epigenomics Successfully Completes Larger Clinical Study in Early Lung Cancer Detection
Panel with two biomarkers confirms solid performance in larger blood plasma study
19-Jun-2008 -
Epigenomics AG announced that it successfully completed a larger clinical study in its lung cancer program. The study was run in close collaboration with Prof. Dr. Christian Witt and Dr. Bernd Schmidt at the Charité University Hospital in Berlin, Germany.
The study on 256 patient samples ...
biomarker
biomarkers
Germany
+3